Does stevia affect blood glucose? It is a question increasingly asked by people managing diabetes or trying to reduce their sugar intake. Stevia — derived from the plant Stevia rebaudiana and authorised in the UK as food additive E960 (steviol glycosides) — is a non-nutritive sweetener that is not broken down into glucose by the body. Unlike table sugar, pure stevia extracts do not raise blood glucose or contribute calories. However, many commercial stevia products contain bulking agents that can affect blood sugar, making label-reading essential. This article examines the science, UK regulatory guidance, and practical advice for using stevia safely.
Summary: Pure steviol glycosides (stevia, E960) do not raise blood glucose or insulin levels, as they are not metabolised into glucose by the body.
- Steviol glycosides (E960) pass through the small intestine largely intact and are broken down by gut bacteria, not converted to glucose.
- Clinical trials show pure stevia does not produce a significant postprandial rise in blood glucose or insulin compared to placebo.
- Many commercial stevia products contain bulking agents such as maltodextrin or dextrose, which can raise blood glucose — always check labels.
- EFSA has set an acceptable daily intake (ADI) of 4 mg per kg of body weight per day as steviol equivalents; children are at greater risk of exceeding this.
- SACN (2023) concluded that low- and no-calorie sweeteners do not raise blood glucose, but long-term health evidence remains limited.
- People taking insulin or glucose-lowering medicines should discuss dietary changes involving stevia with their GP or diabetes care team.
Table of Contents
How Stevia Is Processed by the Body
Steviol glycosides are not absorbed as glucose; they pass to the large intestine, are broken down by gut bacteria into steviol, and excreted as steviol glucuronide in urine, contributing no meaningful calories or carbohydrates.
Stevia is a natural, non-nutritive sweetener derived from the leaves of the plant Stevia rebaudiana, native to South America. In the UK and across Great Britain, only high-purity steviol glycosides (authorised food additive E960) are permitted for use as a sweetener in food and drink. Crude stevia leaf and whole-leaf extracts are not approved as sweeteners under the GB Food Additives Register (retained Regulation (EC) No 1333/2008).[1][4]
The sweet compounds responsible for stevia's taste — primarily steviol glycosides such as stevioside and rebaudioside A — are not absorbed in the small intestine in the same way as conventional sugars. They pass largely intact into the large intestine, where gut bacteria break them down into steviol. Steviol is then absorbed, conjugated in the liver to form steviol glucuronide, and excreted predominantly in the urine, with a small proportion eliminated in the faeces. This metabolic pathway has been characterised in the EFSA Scientific Opinions on steviol glycosides (2010; re-evaluated 2015).[6]
Because steviol glycosides are not metabolised into glucose, they do not contribute calories or carbohydrates to the diet in any meaningful quantity. This is a fundamental distinction from sucrose (table sugar) or other carbohydrate-based sweeteners, which are broken down into glucose and fructose and directly raise blood glucose levels.
It is important to note that commercially available stevia products vary considerably. Some blended stevia products contain bulking agents such as maltodextrin or dextrose, which can raise blood glucose. Consumers — particularly those managing diabetes — should always check the ingredient label carefully and choose products listing steviol glycosides or rebaudioside A as the primary sweetener.
| Aspect | Finding / Guidance | Evidence Source | Clinical Note |
|---|---|---|---|
| Effect on blood glucose | Pure steviol glycosides (E960) do not raise blood glucose or insulin levels when consumed in place of sugar | Multiple RCTs; SACN 2023 review | Applies to pure extracts only; blended products may differ |
| Postprandial glucose response | Stevia preloads associated with lower postprandial glucose and insulin vs sucrose, with no compensatory caloric increase | Anton et al., 2010 (Appetite) | Acute effect only; long-term HbA1c benefit not firmly established |
| Insulinotropic / GLP-1 effects | Possible mild glucose-dependent insulin stimulation and GLP-1 modulation suggested in some studies | Preliminary human studies | Evidence inconsistent; clinical relevance in humans uncertain |
| Risk of hypoglycaemia | Stevia itself does not cause hypoglycaemia in healthy individuals | Current clinical evidence | Indirect risk if overall carbohydrate intake falls in those on insulin or glucose-lowering medicines |
| Blended retail products | Products containing maltodextrin or dextrose as bulking agents can raise blood glucose | Article guidance; FSA labelling rules | Always check ingredient label; choose products listing steviol glycosides or rebaudioside A |
| Acceptable daily intake (ADI) | 4 mg/kg body weight/day expressed as steviol equivalents (≈280 mg/day for a 70 kg adult) | EFSA 2010; re-evaluated 2015 | Children reach ADI more readily due to lower body weight; monitor intake |
| NHS / NICE position | NICE (NG28) supports reducing free sugars; NHS acknowledges sweeteners as a useful tool for diabetes management | NICE NG28; NHS Eatwell Guide; SACN 2023 | No specific endorsement of stevia; discuss significant dietary changes with GP or diabetes care team |
Stevia and Blood Glucose: What the Evidence Shows
Pure steviol glycoside extracts do not raise blood glucose or insulin levels; randomised trials show lower postprandial glucose compared to sucrose, though long-term glycaemic benefits such as HbA1c improvement are not firmly established.
A growing body of clinical research has examined whether stevia affects blood glucose levels, particularly in people with type 2 diabetes or insulin resistance. The overall evidence suggests that pure steviol glycoside extracts (E960) do not raise blood glucose or insulin levels when consumed in place of sugar.
Several randomised controlled trials have demonstrated that consuming stevia before or with a meal does not produce a significant postprandial (after-meal) rise in blood glucose compared to a placebo. A frequently cited study published in Appetite (Anton et al., 2010) found that participants who consumed stevia preloads had lower postprandial glucose and insulin levels compared to those who consumed sucrose, without compensatory increases in caloric intake later in the day.[8] These findings relate to acute postprandial effects; long-term glycaemic outcomes — such as improvements in HbA1c — are not yet firmly established, and current evidence does not support claims of clinically meaningful benefit over time.
Some smaller studies have suggested that steviol glycosides may have a mild insulinotropic effect — meaning they could stimulate insulin secretion from pancreatic beta cells in a glucose-dependent manner.[9] Researchers have also explored potential effects on glucagon-like peptide-1 (GLP-1), a hormone involved in blood sugar regulation. Both lines of evidence remain preliminary, with uncertain clinical relevance in humans, and findings are inconsistent across studies.
The Scientific Advisory Committee on Nutrition (SACN, 2023) has reviewed the evidence on low- and no-calorie sweeteners (LNCS) and concluded that, while they do not raise blood glucose, the evidence on long-term health outcomes remains limited and uncertain.[10]
There is no evidence that stevia causes hypoglycaemia (low blood sugar) in healthy individuals. However, for people taking insulin or glucose-lowering medicines, any dietary change — including substituting sugar with stevia — may indirectly affect blood glucose management, particularly if overall carbohydrate intake falls. Such changes should always be discussed with a healthcare professional.
NHS and NICE Guidance on Sweeteners and Blood Sugar
NICE and the NHS support reducing free sugar intake but do not specifically endorse stevia; EFSA's ADI for steviol glycosides is 4 mg per kg of body weight per day, a level unlikely to be exceeded by most adults through normal dietary use.
In Great Britain, steviol glycosides are authorised as food additive E960 under the GB Food Additives Register, with specifications set out in retained Regulation (EU) No 231/2012. The European Food Safety Authority (EFSA) has established an acceptable daily intake (ADI) of 4 mg per kg of body weight per day, expressed as steviol equivalents, for steviol glycosides (E960).[2][6] For an average adult weighing 70 kg, this equates to approximately 280 mg of steviol equivalents per day — a level unlikely to be exceeded through normal dietary use, though parents should be mindful that children's lower body weight means the ADI may be reached more readily with frequent consumption of stevia-sweetened products.
NICE guidance on type 2 diabetes in adults (NG28) focuses on reducing free sugar intake and improving overall dietary quality as part of diabetes management.[13] NICE does not specifically endorse or recommend individual non-nutritive sweeteners such as stevia; rather, it supports strategies to reduce free sugars as part of a balanced diet. The NHS similarly acknowledges that sweeteners can be a useful tool for people trying to cut down on sugar, particularly those managing diabetes or following a calorie-controlled diet, and the NHS Eatwell Guide encourages reducing overall sugar consumption.
NHS guidance cautions against over-reliance on sweetened products — whether sugar-containing or not — as part of a healthy, balanced diet. There is ongoing scientific debate about whether habitual use of sweeteners may influence sweet taste preferences or gut microbiome composition; however, current evidence, including the SACN (2023) review of LNCS, is insufficient to support firm clinical recommendations in this area.
Patients with diabetes are advised to discuss any significant dietary changes with their GP or diabetes care team. If you believe you have experienced an adverse reaction to a food additive, you can report this to your GP and via the Food Standards Agency's 'Report a food problem' service.[15]
Practical Advice on Using Stevia as Part of a Balanced Diet
Pure steviol glycosides are safe for most people, including those with type 2 diabetes, but label-checking is essential to avoid blended products containing glucose-raising bulking agents such as maltodextrin or dextrose.
For most people, including those with type 2 diabetes or non-diabetic hyperglycaemia, using pure steviol glycosides (E960) as a substitute for sugar is considered safe and unlikely to negatively affect blood glucose control. It can be a practical option for sweetening hot drinks, cereals, or home baking without adding calories or carbohydrates. However, a few key considerations are worth bearing in mind:
-
Check product labels carefully: Many retail stevia products are blended with other ingredients. Look for products listing steviol glycosides or rebaudioside A as the primary sweetener, and avoid those with added maltodextrin or dextrose if you are closely monitoring blood glucose. Products blended with polyols (such as erythritol) may also cause digestive discomfort in some people.
-
Use in moderation and stay within the ADI: While stevia is well tolerated by most people, very high intakes may cause digestive discomfort such as bloating or nausea in some individuals. This is more likely with products containing carbohydrate bulking agents or polyols. Monitor your own tolerance. Parents should be particularly mindful of the ADI for children, given their lower body weight.
-
Do not use sweeteners as a licence to overconsume: Replacing sugar with stevia in an otherwise unbalanced diet is unlikely to deliver significant health benefits. The focus should remain on overall dietary quality — plenty of vegetables, wholegrains, lean proteins, and healthy fats, in line with the NHS Eatwell Guide.
-
Monitor your blood glucose if you have diabetes: If you self-monitor blood glucose and make changes to your sweetener use, keep a record of any changes in your readings and discuss them with your diabetes care team. If your overall carbohydrate intake changes significantly, your medication doses may need review.
-
Know the signs of hypoglycaemia: Symptoms include shakiness, sweating, confusion, and palpitations. If you experience these, follow NHS guidance on treating hypoglycaemia promptly — typically by consuming 15–20 g of fast-acting carbohydrate.[14] For severe symptoms (such as loss of consciousness), call 999. Stevia itself does not cause hypoglycaemia, but changes in diet alongside glucose-lowering medicines can affect blood sugar levels.
If you have concerns about your diet and diabetes management, contact your GP or diabetes nurse. Further practical information is available from Diabetes UK on low-calorie sweeteners and diabetes. Stevia is a useful dietary tool, but it works best as part of a broader, evidence-based approach to healthy eating and blood sugar management.
Scientific References
- Approved additives and E numbers – Food Standards Agency.
- Outcome of Assessment of the Modification of use of Steviol Glycosides (RP1140).
- The truth about sweeteners – NHS.
- Assessment for the Application for a change in the Steviol Glycoside specification in Great Britain.
- Outcome of Assessment of the Modification of use of Steviol Glycosides (RP1084, published version).
- Outcome of Assessment of the Modification of use of Steviol Glycosides (RP1084, DOI version).
- Pharmacokinetics of Oral Rebaudioside A in Patients with Type 2 Diabetes Mellitus and Its Effects on Glucose Homeostasis: A Placebo-Controlled Crossover Trial.
- Effects of stevia, aspartame, and sucrose on food intake, satiety, and postprandial glucose and insulin levels (Anton et al.).
- Stevioside acts directly on pancreatic beta cells to secrete insulin: actions independent of cyclic adenosine monophosphate and adenosine triphosphate-sensitive K+-channel activity.
- SACN annual report 2023 – summary.
- Consultation on the specification for food additive rebaudioside M (E 960c).
- Food Standards Agency: steviol glycoside specifications (node/12266).
- Type 2 diabetes in adults: management (NG28) – NICE.
- Hypoglycaemia – Treatment summaries – BNF/NICE.
- For consumers – Report a food problem – Food Standards Agency.
Frequently Asked Questions
Is stevia safe for people with type 2 diabetes?
Pure steviol glycosides (E960) are considered safe for people with type 2 diabetes and do not raise blood glucose. However, blended stevia products containing maltodextrin or dextrose can affect blood sugar, so always check the ingredient label and discuss significant dietary changes with your GP or diabetes care team.
Can stevia cause low blood sugar (hypoglycaemia)?
Stevia itself does not cause hypoglycaemia in healthy individuals. However, people taking insulin or glucose-lowering medicines who significantly reduce their carbohydrate intake by substituting sugar with stevia may experience changes in blood glucose levels and should seek advice from their healthcare professional.
Which stevia products are approved for use in the UK?
In the UK, only high-purity steviol glycosides authorised as food additive E960 are permitted as sweeteners under the GB Food Additives Register. Crude stevia leaf and whole-leaf extracts are not approved, so consumers should look for E960 or rebaudioside A on product labels.
The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.
The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.
Any third-party brands or services referenced on this site are included for informational purposes only; we are entirely independent and have no affiliation, partnership, or collaboration with any companies mentioned.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Heading 6
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
- Item 1
- Item 2
- Item 3
Unordered list
- Item A
- Item B
- Item C
Bold text
Emphasis
Superscript
Subscript








